Client Stories

A woman in her late 40s came to BalanceMD with a constellation of complaints that had been building for several years: progressive fatigue, difficulty sleeping, weight that was resistant to her usual efforts, and a feeling she described with surprising precision as "losing herself." She was functioning — going to work, managing her household — but she was operating at a fraction of her previous capacity, and she knew it.

Her primary care labs were all within normal ranges. She had been reassured repeatedly that nothing was wrong. One physician had attributed her symptoms to stress and recommended therapy. Another had suggested antidepressants. She had declined both — not because she was against treatment, but because she was convinced the source was physiological, not psychological.

Advanced hormonal evaluation revealed what standard screening had missed entirely: declining estrogen and progesterone consistent with perimenopause, testosterone in the low range for her age, and early insulin resistance detectable on fasting insulin — invisible to a standard glucose check. The tree was struggling at the root. Her symptoms — the fatigue, the weight, the disrupted sleep, the sense of lost self — were all downstream expressions of a hormonal and metabolic environment that had quietly shifted beneath conventional medicine's radar.

Dr. Bryant built a protocol that addressed both layers: bioidentical hormone restoration — estrogen, progesterone, and testosterone — titrated to her clinical picture, alongside metabolic recalibration through the Balance Spectrum to address the insulin pattern driving weight resistance and energy disruption. Terrain support addressed her sleep architecture, which had been compromised for years.

Within 90 days, her energy had returned meaningfully. Sleep quality improved — she was falling asleep more easily and waking rested. Her weight began responding to the same efforts that had previously yielded nothing. Most significantly, the feeling she described as "losing herself" resolved. She felt, in her words, like herself again.

A woman with severe gastroparesis — a condition in which the stomach empties too slowly — had already been through the gastroenterology system. She had seen multiple specialists. She had received the diagnosis and the standard pharmacological options. She had been told, in the way that specialists sometimes deliver this news, that not much more could be done. She could barely eat without significant discomfort, and she was losing weight progressively.

Conventional gastroenterology had focused on the stomach — the organ that was visibly dysfunctional. This is the expected approach, and it is often the right one. But it had reached its limit. The stomach was being managed in isolation, without any evaluation of the metabolic environment in which it was operating.

Rather than treating gastroparesis as a fixed GI condition, Dr. Bryant asked a different question: what is the metabolic environment doing to the autonomic nervous system, and to GI motility in particular? A comprehensive evaluation revealed significant findings beyond the stomach — hormonal imbalances affecting autonomic tone, nutrient deficiencies impairing cellular function, and a metabolic picture that was contributing to the autonomic dysfunction driving the gastroparesis itself. The stomach was not the problem. It was a symptom of the problem.

A systems-level protocol addressed the root metabolic environment rather than the gastric symptom alone. This included targeted nutritional support to correct identifiable deficiencies, hormonal correction to support autonomic regulation, and dietary modification through the Balance Spectrum that reduced the metabolic burden on an already-stressed GI system.

GI motility improved meaningfully. She was able to eat with less difficulty. Weight stabilized and then began recovering. Her quality of life — which had been severely diminished by the inability to eat normally — improved substantially. The gastroparesis was not "cured" in any absolute sense, but the metabolic context that had been driving its severity was addressed, and the results spoke for themselves.

An elderly client presented with acute confusion — disorientation, difficulty following conversation, and a noticeable decline from baseline cognition that had developed over a relatively short period. Confusion in an older adult typically triggers a neurological workup: imaging, cognitive testing, evaluation for stroke, dementia, or delirium from infection. That reflex is appropriate and often necessary. In this case, it was where conventional evaluation began.

The neurological workup was unrevealing. No structural cause for the confusion was identified. The confusion, however, remained. The metabolic evaluation that followed — the kind that a metabolic-first approach demands before defaulting to further neurological investigation — identified a severe thiamine (vitamin B1) deficiency. Thiamine is essential for neurological function, and its absence can produce acute and profound cognitive effects. It is a treatable, reversible metabolic cause of what presents as a neurological symptom.

Targeted thiamine supplementation was initiated. The correction was straightforward once the deficiency was identified. The clinical lesson is not that the supplement was complex — it was not. The lesson is that the metabolic-first lens was applied to a presentation that conventional medicine had defaulted to treating neurologically, and that applying that lens revealed a cause that standard neurological evaluation was not designed to find.

The confusion resolved. Cognitive function returned to baseline. The client and family, who had been frightened by the presentation and uncertain what was causing it, had an answer and a resolution. This case is a clear illustration of a core principle: the metabolic layer of the Tree Model must be evaluated thoroughly before attributing symptoms to other causes — because metabolic causes are often more treatable, and more common, than they appear.